{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:20:31Z","timestamp":1775218831183,"version":"3.50.1"},"reference-count":28,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2025]]},"DOI":"10.3960\/jslrt.25046","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T22:07:51Z","timestamp":1764281271000},"page":"305-311","source":"Crossref","is-referenced-by-count":1,"title":["Primary large B-cell lymphoma of the central nervous system mimicking inflammatory myelitis at initial presentation"],"prefix":"10.3960","volume":"65","author":[{"given":"Satoshi","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan,"},{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuki","family":"Imanishi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan,"},{"name":"Medical Student, Tohoku Medical and Pharmaceutical University, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan,"},{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Hatta","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Okitsu","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narumi","family":"Okajima","sequence":"additional","affiliation":[{"name":"Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyoshi","family":"Fujishima","sequence":"additional","affiliation":[{"name":"Division of Pathology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Kameoka","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Ishii","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Villano JL, Koshy M, Shaikh H, Dolecek TA, McCarthy BJ. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer. 2011; 105: 1414-1418.","DOI":"10.1038\/bjc.2011.357"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Ferreri AJM, Illerhaus G, Doorduijn JK <i>et al.<\/i> Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024; 35: 491-507.","DOI":"10.1016\/j.annonc.2023.11.010"},{"key":"3","unstructured":"3 Board WCoTE. Haematolymphoid Tumours: WHO Classification of Tumours. 5th ed, Lyon, IARC. 2024."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ge H, Xu L, Gao H, Ji S. Primary intramedullary spinal cord lymphoma misdiagnosed as longitudinally extensive transverse myelitis: a case report and literature review. BMC Neurol. 2023; 23: 352.","DOI":"10.1186\/s12883-023-03383-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Chiavazza C, Pellerino A, Ferrio F <i>et al.<\/i> Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring. BioMed Res Int. 2018; 2018: 3606970.","DOI":"10.1155\/2018\/3606970"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 de Koning ME, Hof JJ, Jansen C <i>et al.<\/i> Primary central nervous system lymphoma. J Neurol. 2024; 271: 2906-2913.","DOI":"10.1007\/s00415-023-12143-w"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Barrantes-Freer A, Engel AS, Rodriguez-Villagra OA <i>et al.<\/i> Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination. Brain Pathol. 2018; 28: 225-233.","DOI":"10.1111\/bpa.12496"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Zara P, Dinoto A, Carta S <i>et al.<\/i> Non-demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review. Eur J Neurol. 2023; 30: 3367-3376.","DOI":"10.1111\/ene.15983"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ser MH, G\u00fclec B, Saliho\u011flu A, Uyguno\u011flu U. Longitudinally extensive transverse myelitis preceding primary central nervous system lymphoma: spinal sentinel neuroinflammation. J Spinal Cord Med. 2023; 46: 521-524.","DOI":"10.1080\/10790268.2022.2087137"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Norrington M, Rathi N, Jenkinson MD, Mills SJ. Neuroinflammation preceding primary central nervous system lymphoma (PCNSL) - Case reports and literature review. J Clin Neurosci. 2021; 89: 381-388.","DOI":"10.1016\/j.jocn.2021.05.038"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Lu JQ, O\u2019Kelly C, Girgis S <i>et al.<\/i> Neuroinflammation preceding and accompanying primary central nervous system lymphoma: case study and literature review. World Neurosurg. 2016; 88: 692.e1-692.e8.","DOI":"10.1016\/j.wneu.2015.11.099"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Alderson L, Fetell MR, Sisti M <i>et al.<\/i> Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry. 1996; 60: 102-105.","DOI":"10.1136\/jnnp.60.1.102"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kvarta MD, Sharma D, Castellani RJ <i>et al.<\/i> Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination. BMC Neurol. 2016; 16: 72.","DOI":"10.1186\/s12883-016-0596-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 DeAngelis LM. Primary central nervous system lymphoma imitates multiple sclerosis. J Neurooncol. 1990; 9: 177-181.","DOI":"10.1007\/BF02427840"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Davies G, Keir G, Thompson EJ, Giovannoni G. The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study. Neurology. 2003; 60: 1163-1166.","DOI":"10.1212\/01.WNL.0000055864.08740.CB"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 2013; 70: 311-319.","DOI":"10.1001\/jamaneurol.2013.606"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Cerqua R, Balestrini S, Perozzi C <i>et al.<\/i> Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme. Neurol Sci. 2016; 37: 23-29.","DOI":"10.1007\/s10072-015-2353-4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Scheichel F, Marhold F, Pinggera D <i>et al.<\/i> Influence of preoperative corticosteroid treatment on rate of diagnostic surgeries in primary central nervous system lymphoma: a multicenter retrospective study. BMC Cancer. 2021; 21: 754.","DOI":"10.1186\/s12885-021-08515-y"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Baraniskin A, Schroers R. Modern cerebrospinal fluid analyses for the diagnosis of diffuse large B-cell lymphoma of the CNS. CNS Oncol. 2014; 3: 77-85.","DOI":"10.2217\/cns.13.63"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Song Y, Zhang W, Zhang L <i>et al.<\/i> Cerebrospinal fluid IL-10 and IL-10\/IL-6 as accurate diagnostic biomarkers for primary central nervous system large B-cell lymphoma. Sci Rep. 2016; 6: 38671.","DOI":"10.1038\/srep38671"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Yamaguchi J, Ohka F, Kitano Y <i>et al.<\/i> Rapid detection of the MYD88 L265P mutation for pre- and intra-operative diagnosis of primary central nervous system lymphoma. Cancer Sci. 2023; 114: 2544-2551.","DOI":"10.1111\/cas.15762"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Watanabe J, Natsumeda M, Okada M <i>et al.<\/i> High detection rate of MYD88 mutations in cerebrospinal fluid from patients with CNS lymphomas. JCO Precis Oncol. 2019; 3: 1-13.","DOI":"10.1200\/PO.18.00308"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Valyraki N, Ahle G, Tabouret E <i>et al.<\/i> Primary central nervous system lymphoma of the spinal cord: A LOC network cohort study. Rev Neurol (Paris). 2025; 181: 200-209.","DOI":"10.1016\/j.neurol.2024.11.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Sheng X, Xu M, Li X. A case of primary central nervous system lymphoma mimic neuromyelitis optica. Transl Neurosci. 2020; 11: 28-33.","DOI":"10.1515\/tnsci-2020-0005"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Flanagan EP, O\u2019Neill BP, Porter AB <i>et al.<\/i> Primary intramedullary spinal cord lymphoma. Neurology. 2011; 77: 784-791.","DOI":"10.1212\/WNL.0b013e31822b00b9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Shigekawa S, Inoue A, Miyazaki Y <i>et al.<\/i> Essentials for early diagnosis of primary intramedullary spinal cord lymphoma. How to suspect primary intramedullary spinal cord lymphoma early and proceed to invasive biopsy? A case report and literature review. Surg Neurol Int. 2024; 15: 41.","DOI":"10.25259\/SNI_8_2024"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Okabe H, Ochi M, Matsumoto S, Ohyagi Y. Primary intramedullary lymphoma with a long spinal cord lesion. Intern Med. 2024; 63: 1519-1520.","DOI":"10.2169\/internalmedicine.2621-23"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Kong L, Raunio S. Primary central nervous system lymphoma presenting as an isolated intramedullary spinal cord lesion: a case report. AME Case Rep. 2023; 7: 10.","DOI":"10.21037\/acr-22-41"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/4\/65_25046\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:41:44Z","timestamp":1766810504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/4\/65_25046\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.25046","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25046"}}